CoChat
Sign Up
Cited by 212

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses.

Eckhard, Ulrich, Huesgen, Pitter F., Schilling, Oliver, Bellac, Caroline L., Butler, Georgina S., Cox, Jennifer H., Dufour, Antoine, Goebeler, Verena, Kappelhoff, Reinhild, Keller, Ulrich auf dem, Klein, Theo, Lange, Philipp F., Marino, Giada, Morrison, Charlotte J., Prudova, Anna, Rodriguez, David, Starr, Amanda E., Wang, Yili, Overall, Christopher M.·2016·Matrix Biology
DOI 10.1016/j.matbio.2015.09.003
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.matbio.2015.09.003

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 9 references

Research works printed but not linked: 101

  1. Tallant, 2010, Matrix metalloproteinases: fold and function of their catalytic domains, Biochim. Biophys. Acta, 1803, 20-8
  2. Maskos, 2003, Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases, Mol. Biotechnol., 25, 241, 10.1385/MB:25:3:241 · DOI
  3. Murphy, 2008, Progress in matrix metalloproteinase research, Mol. Asp. Med., 29, 290, 10.1016/j.mam.2008.05.002 · DOI
  4. Nagase, 2006, Structure and function of matrix metalloproteinases and TIMPs, Cardiovasc. Res., 69, 562, 10.1016/j.cardiores.2005.12.002 · DOI
  5. Butler, 2009, Updated biological roles for matrix metalloproteinases and new “intracellular” substrates revealed by degradomics, Biochemistry (Mosc), 48, 10830, 10.1021/bi901656f · DOI
  6. Chen, 2007, Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinases during mouse embryonic development, Reprod. Camb. Engl., 133, 405, 10.1530/rep.1.01020 · DOI
  7. Deryugina, 2015, Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature, Matrix Biol. J. Int. Soc. Matrix Biol., 44–46, 94, 10.1016/j.matbio.2015.04.004 · DOI
  8. Itoh, 2006, MT1-MMP: a key regulator of cell migration in tissue, IUBMB Life, 58, 589, 10.1080/15216540600962818 · DOI
  9. Aiken, 2010, Unraveling metalloproteinase function in skeletal biology and disease using genetically altered mice, Biochim. Biophys. Acta, 1803, 121, 10.1016/j.bbamcr.2009.07.002 · DOI
  10. Giannelli, 1997, Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5, Science, 277, 225, 10.1126/science.277.5323.225 · DOI · Paper page
  11. Xu, 2001, Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo, J. Cell Biol., 154, 1069, 10.1083/jcb.200103111 · DOI
  12. Agnihotri, 2001, Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin), J. Biol. Chem, 276, 28261, 10.1074/jbc.M103608200 · DOI
  13. Sage, 2003, Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis, J. Biol. Chem, 278, 37849, 10.1074/jbc.M302946200 · DOI
  14. Monboisse, 1840, Matrikines from basement membrane collagens: a new anti-cancer strategy, Biochim. Biophys. Acta, 2014, 2589
  15. Butler, 2013, Matrix metalloproteinase processing of signaling molecules to regulate inflammation, Periodontol., 63, 123, 10.1111/prd.12035 · DOI
  16. Morrison, 2009, Matrix metalloproteinase proteomics: substrates, targets, and therapy, Curr. Opin. Cell Biol., 21, 645, 10.1016/j.ceb.2009.06.006 · DOI
  17. Schlage, 2015, Proteomic approaches to uncover MMP function, Matrix Biol. J. Int. Soc. Matrix Biol., 44–46, 232, 10.1016/j.matbio.2015.01.003 · DOI
  18. Fortelny, 2014, Network analyses reveal pervasive functional regulation between proteases in the human protease web, PLoS Biol., 12, 10.1371/journal.pbio.1001869 · DOI
  19. Sturrock, 2014, Highlight: the protease web, Biol. Chem., 395, 1133, 10.1515/hsz-2014-0237 · DOI
  20. Auf dem Keller, 2013, Systems-level analysis of proteolytic events in increased vascular permeability and complement activation in skin inflammation, Sci. Signal., 6, 10.1126/scisignal.2003512 · DOI
  21. Bellac, 2014, Macrophage matrix metalloproteinase-12 dampens inflammation and neutrophil influx in arthritis, Cell Rep., 9, 618, 10.1016/j.celrep.2014.09.006 · DOI
  22. Haro, 2000, Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption, J. Clin. Invest., 105, 143, 10.1172/JCI7091 · DOI
  23. Suzuki, 1997, Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site, J. Biol. Chem., 272, 31730, 10.1074/jbc.272.50.31730 · DOI
  24. Zhang, 2003, HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration, Nat. Neurosci., 6, 1064, 10.1038/nn1127 · DOI
  25. McQuibban, 2000, Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3, Science, 289, 1202, 10.1126/science.289.5482.1202 · DOI
  26. Wilson, 1999, Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense, Science, 286, 113, 10.1126/science.286.5437.113 · DOI
  27. Poulalhon, 2006, Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin. A direct role as an antifibrotic agent?, J. Biol. Chem., 281, 33045, 10.1074/jbc.M606366200 · DOI
  28. Dufour, 2013, Missing the target: matrix metalloproteinase antitargets in inflammation and cancer, Trends Pharmacol. Sci., 34, 233, 10.1016/j.tips.2013.02.004 · DOI
  29. Shay, 2015, Moving targets: emerging roles for MMPs in cancer progression and metastasis, Matrix Biol. J. Int. Soc. Matrix Biol., 44–46, 200, 10.1016/j.matbio.2015.01.019 · DOI
  30. Bonnans, 2014, Remodelling the extracellular matrix in development and disease, Nat. Rev. Mol. Cell Biol., 15, 786, 10.1038/nrm3904 · DOI · Paper page
  31. Cox, 2011, Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer, Dis. Model. Mech., 4, 165, 10.1242/dmm.004077 · DOI · Paper page
  32. Kessenbrock, 2015, Matrix metalloproteinases in stem cell regulation and cancer, Matrix Biol. J. Int. Soc. Matrix Biol., 44–46, 184, 10.1016/j.matbio.2015.01.022 · DOI
  33. Itoh, 2015, Membrane-type matrix metalloproteinases: their functions and regulations, Matrix Biol. J. Int. Soc. Matrix Biol., 44–46, 207, 10.1016/j.matbio.2015.03.004 · DOI · Paper page
  34. Overall, 2002, Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites, Mol. Biotechnol., 22, 51, 10.1385/MB:22:1:051 · DOI
  35. Patterson, 2001, Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain, FEBS Lett., 503, 158, 10.1016/S0014-5793(01)02723-5 · DOI
  36. Steffensen, 1995, Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen, J. Biol. Chem., 270, 11555, 10.1074/jbc.270.19.11555 · DOI
  37. Gomis-Rüth, 1824, A standard orientation for metallopeptidases, Biochim. Biophys. Acta, 2012, 157
  38. Harris, 2000, Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries, Proc. Natl. Acad. Sci., 97, 7754, 10.1073/pnas.140132697 · DOI
  39. Kasperkiewicz, 2012, Current and prospective applications of non-proteinogenic amino acids in profiling of proteases substrate specificity, Biol. Chem., 393, 843, 10.1515/hsz-2012-0167 · DOI
  40. Schilling, 2007, Proteomic discovery of protease substrates, Curr. Opin. Chem. Biol., 11, 36, 10.1016/j.cbpa.2006.11.037 · DOI
  41. Schilling, 2008, Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites, Nat. Biotechnol., 26, 685, 10.1038/nbt1408 · DOI
  42. Schilling, 2011, Characterization of the prime and non-prime active site specificities of proteases by proteome-derived peptide libraries and tandem mass spectrometry, Nat. Protoc., 6, 111, 10.1038/nprot.2010.178 · DOI
  43. Barré, 2014, Cleavage specificity analysis of six type II transmembrane serine proteases (TTSPs) using PICS with proteome-derived peptide libraries, PLoS One, 9, 10.1371/journal.pone.0105984 · DOI
  44. Becker-Pauly, 2011, Proteomic analyses reveal an acidic prime side specificity for the astacin metalloprotease family reflected by physiological substrates, Mol. Cell Proteomics, 10, 10.1074/mcp.M111.009233 · DOI
  45. Cruz, 2014, RC1339/APRc from Rickettsia conorii is a novel aspartic protease with properties of retropepsin-like enzymes, PLoS Pathog., 10, 10.1371/journal.ppat.1004324 · DOI
  46. Eckhard, 2014, Proteomic protease specificity profiling of clostridial collagenases reveals their intrinsic nature as dedicated degraders of collagen, J. Proteome, 100, 102, 10.1016/j.jprot.2013.10.004 · DOI
  47. Marino, 2014, Family-wide characterization of matrix metalloproteinases from Arabidopsis thaliana reveals their distinct proteolytic activity and cleavage site specificity, Biochem. J., 457, 335, 10.1042/BJ20130196 · DOI
  48. Turk, 2001, Determination of protease cleavage site motifs using mixture-based oriented peptide libraries, Nat. Biotechnol., 19, 661, 10.1038/90273 · DOI
  49. Chen, 2003, A residue in the S2 subsite controls substrate selectivity of matrix metalloproteinase-2 and matrix metalloproteinase-9, J. Biol. Chem, 278, 17158, 10.1074/jbc.M210324200 · DOI
  50. Kridel, 2001, Substrate hydrolysis by matrix metalloproteinase-9, J. Biol. Chem, 276, 20572, 10.1074/jbc.M100900200 · DOI
  51. Reiter, 1999, Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket, Bioorg. Med. Chem. Lett., 9, 127, 10.1016/S0960-894X(98)00729-X · DOI
  52. Deng, 2000, Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library, J. Biol. Chem., 275, 31422, 10.1074/jbc.M004538200 · DOI
  53. McGeehan, 1994, Characterization of the peptide substrate specificities of interstitial collagenase and 92-kDa gelatinase. Implications for substrate optimization, J. Biol. Chem., 269, 32814, 10.1016/S0021-9258(20)30064-8 · DOI
  54. Smith, 1995, Rapid identification of highly active and selective substrates for stromelysin and matrilysin using bacteriophage peptide display libraries, J. Biol. Chem., 270, 6440, 10.1074/jbc.270.12.6440 · DOI
  55. Nagase, 1994, Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3), J. Biol. Chem., 269, 20952, 10.1016/S0021-9258(17)31914-2 · DOI
  56. Nagase, 1996, Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides, Biopolymers, 40, 399, 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R · DOI
  57. Netzel-Arnett, 1993, Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin), Biochemistry (Mosc), 32, 6427, 10.1021/bi00076a016 · DOI
  58. Bode, 1999, Structural properties of matrix metalloproteinases, Cell Mol. Life Sci., 55, 639, 10.1007/s000180050320 · DOI
  59. Ratnikov, 2014, Basis for substrate recognition and distinction by matrix metalloproteinases, Proc. Natl. Acad. Sci. U. S. A., 111, E4148, 10.1073/pnas.1406134111 · DOI
  60. Dean, 2008, Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx, Blood, 112, 3455, 10.1182/blood-2007-12-129080 · DOI
  61. Rawlings, 2014, MEROPS: the database of proteolytic enzymes, their substrates and inhibitors, Nucleic Acids Res., 42, D503, 10.1093/nar/gkt953 · DOI
  62. Overall, 2002, Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics, Biol. Chem., 383, 1059, 10.1515/BC.2002.114 · DOI
  63. Li, 2002, Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury, Cell, 111, 635, 10.1016/S0092-8674(02)01079-6 · DOI
  64. Knight, 1992, A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases, FEBS Lett., 296, 263, 10.1016/0014-5793(92)80300-6 · DOI
  65. London, 2011, Rosetta FlexPepDock web server—high resolution modeling of peptide–protein interactions, Nucleic Acids Res., 39, W249, 10.1093/nar/gkr431 · DOI
  66. Kukreja, 2015, High-throughput multiplexed peptide-centric profiling illustrates both substrate cleavage redundancy and specificity in the MMP family, Chem. Biol., 22, 1122, 10.1016/j.chembiol.2015.07.008 · DOI
  67. Prudova, 2010, Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics, Mol. Cell Proteomics, 9, 894, 10.1074/mcp.M000050-MCP201 · DOI
  68. Kohno, 2006, Crystal structures of the catalytic domain of human stromelysin-1 (MMP-3) and collagenase-3 (MMP-13) with a hydroxamic acid inhibitor SM-25453, Biochem. Biophys. Res. Commun., 344, 315, 10.1016/j.bbrc.2006.03.098 · DOI
  69. Kleifeld, 2010, Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products, Nat. Biotechnol., 28, 281, 10.1038/nbt.1611 · DOI
  70. Kleifeld, 2011, Identifying and quantifying proteolytic events and the natural N terminome by terminal amine isotopic labeling of substrates, Nat. Protoc., 6, 1578, 10.1038/nprot.2011.382 · DOI
  71. Fields, 2015, New strategies for targeting matrix metalloproteinases, Matrix Biol. J. Int. Soc. Matrix Biol., 44–46, 239, 10.1016/j.matbio.2015.01.002 · DOI · Paper page
  72. Sela-Passwell, 2011, New opportunities in drug design of metalloproteinase inhibitors: combination between structure–function experimental approaches and systems biology, Expert Opin. Drug Discov., 6, 527, 10.1517/17460441.2011.560936 · DOI
  73. Morrison, 2006, TIMP independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin C domains, J. Biol. Chem., 281, 26528, 10.1074/jbc.M603331200 · DOI
  74. Butler, 2004, The canonical methionine 392 of matrix metalloproteinase 2 (gelatinase A) is not required for catalytic efficiency or structural integrity: probing the role of the methionine-turn in the metzincin metalloprotease superfamily, J. Biol. Chem., 279, 15615, 10.1074/jbc.M312727200 · DOI
  75. Rozanov, 2003, Membrane type-1 matrix metalloproteinase functions as a proprotein self-convertase. Expression of the latent zymogen in Pichia pastoris, autolytic activation, and the peptide sequence of the cleavage forms, J. Biol. Chem, 278, 8257, 10.1074/jbc.M213246200 · DOI · Paper page
  76. The UniProt Consortium, 2014, Activities at the Universal Protein Resource (UniProt), Nucleic Acids Res., 42, D191, 10.1093/nar/gku469 · DOI
  77. Craig R, Beavis RC. TANDEM: matching proteins with tandem mass spectra. Bioinforma Oxf. Engl. 2004;20:1466–7. doi:http://dx.doi.org/10.1093/bioinformatics/bth092. · DOI
  78. Keller, 2002, Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search, Anal. Chem., 74, 5383, 10.1021/ac025747h · DOI
  79. Keller, 2005, A uniform proteomics MS/MS analysis platform utilizing open XML file formats, Mol. Syst. Biol., 1, 2005.0017, 10.1038/msb4100024 · DOI
  80. Schilling, 2011, Factor Xa subsite mapping by proteome-derived peptide libraries improved using WebPICS, a resource for proteomic identification of cleavage sites, Biol. Chem., 392, 1031, 10.1515/BC.2011.158 · DOI
  81. Kersey, 2004, The International Protein Index: an integrated database for proteomics experiments, Proteomics, 4, 1985, 10.1002/pmic.200300721 · DOI
  82. Colaert, 2009, Improved visualization of protein consensus sequences by iceLogo, Nat. Methods, 6, 786, 10.1038/nmeth1109-786 · DOI
  83. Vizcaíno, 2013, The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013, Nucleic Acids Res., 41, D1063, 10.1093/nar/gks1262 · DOI · Paper page
  84. Abel, 2003, Pre-steady-state kinetics of Bacillus licheniformis 1,3–1,4-beta-glucanase: evidence for a regulatory binding site, Biochem. J., 371, 997, 10.1042/bj20021504 · DOI
  85. Antoni, 2013, Crystallization of bi-functional ligand protein complexes, J. Struct. Biol., 182, 246, 10.1016/j.jsb.2013.03.015 · DOI
  86. Browner, 1995, Matrilysin-inhibitor complexes: common themes among metalloproteases, Biochemistry (Mosc), 34, 6602, 10.1021/bi00020a004 · DOI
  87. Fernandez-Catalan, 1998, Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor, EMBO J., 17, 5238, 10.1093/emboj/17.17.5238 · DOI · Paper page
  88. Hashimoto, 2011, Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor, J. Biol. Chem., 286, 33236, 10.1074/jbc.M111.264176 · DOI
  89. Iyer, 2006, Crystal structure of an active form of human MMP-1, J. Mol. Biol., 362, 78, 10.1016/j.jmb.2006.06.079 · DOI
  90. Matter, 1999, Quantitative structure–activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis, J. Med. Chem., 42, 1908, 10.1021/jm980631s · DOI
  91. Nar, 2001, Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor, J. Mol. Biol., 312, 743, 10.1006/jmbi.2001.4953 · DOI
  92. Steele, 2000, Expression, characterization and structure determination of an active site mutant (Glu202-Gln) of mini-stromelysin-1, Protein Eng., 13, 397, 10.1093/protein/13.6.397 · DOI
  93. Bordoli, 2012, Automated protein structure modeling with SWISS-MODEL Workspace and the Protein Model Portal, Methods Mol. Biol., 857, 107, 10.1007/978-1-61779-588-6_5 · DOI
  94. DeLano, 2005, The case for open-source software in drug discovery, Drug Discov. Today, 10, 213, 10.1016/S1359-6446(04)03363-X · DOI
  95. Yang, 2012, UCSF chimera, MODELLER, and IMP: an integrated modeling system, J. Struct. Biol., 179, 269, 10.1016/j.jsb.2011.09.006 · DOI
  96. Dolinsky, 2004, PDB2PQR: an automated pipeline for the setup of Poisson–Boltzmann electrostatics calculations, Nucleic Acids Res., 32, W665, 10.1093/nar/gkh381 · DOI
  97. Olsson, 2011, PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions, J. Chem. Theory Comput., 7, 525, 10.1021/ct100578z · DOI
  98. Baker, 2001, Electrostatics of nanosystems: application to microtubules and the ribosome, Proc. Natl. Acad. Sci. U. S. A., 98, 10037, 10.1073/pnas.181342398 · DOI
  99. Bond, 2003, TopDraw: a sketchpad for protein structure topology cartoons, Bioinforma Oxf. Engl., 19, 311, 10.1093/bioinformatics/19.2.311 · DOI
  100. Wessel, 1984, A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids, Anal. Biochem., 138, 141, 10.1016/0003-2697(84)90782-6 · DOI
  101. Marchant, 2014, A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity, Nat. Med., 20, 493, 10.1038/nm.3508 · DOI

Cited by

Sorted by citations

See all 212

Metadata

Authors
Eckhard, U., Huesgen, P. F., Schilling, O., Bellac, C. L., Butler, G. S., Cox, J. H., Dufour, A., Goebeler, V., Kappelhoff, R., Keller, U. A. D., Klein, T., Lange, P. F., Marino, G., Morrison, C. J., Prudova, A., Rodriguez, D., Starr, A. E., Wang, Y., & Overall, C. M.
Venue
Matrix Biology
Publisher
Elsevier BV
Published
2016-01
Volume
49
Pages
37-60
ISSN
0945-053X
DOI
10.1016/j.matbio.2015.09.003
Cited by
212
References
9
Language
en
Licence
Funders
  • Canada Research Chair in Metalloproteinase Proteomics and Systems Biology
  • Canadian Institutes of Health Research (MOP-11433, MOP-37937, MOP-111055)
  • Michael Smith Research Foundation for Health Research (MSFHR)
  • Canada Foundations for Innovation (CFI)
  • post-doctoral fellowships from MSFHR
  • German Academic Exchange Service (DAAD)
  • MSFHR
  • fellowships from the German Research Foundation (DFG)
  • postdoctoral fellowships of the Swiss National Science Foundation
  • Novartis Jubilee Foundation
  • Feodor Lynen Research Fellowship of the Alexander von Humboldt Foundation
  • UBC Centre for Blood Research Strategic Training Program in Transfusion Science
  • CBR Internal Collaborative Training Award
  • Natural Sciences and Engineering Research Council of Canada Graduate Scholarships
  • CIHR Strategic Training Fellowships

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review